The subcellular distribution of phosphorylated Y‐box‐binding protein‐1 at S102 in colorectal cancer patients, stratified by KRAS mutational status and clinicopathological features

Oncoprotein Y‐box‐binding protein‐1 (YB‐1) is involved in all cancer hallmarks. One of the most studied post‐translational modifications of YB‐1 is phosphorylation on Serine 102 (S102), which is involved in cancer progression. KRAS mutations are frequent, have been associated with poor prognosis and...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Konstanze Lettau, Stephan Forchhammer, Birgit Fehrenbacher, Lejla Mahmutovic, Marcus Scharpf, Gunnar Blumenstock, Martin Schaller, Irina Bonzheim, Shayan Khozooei, Mahmoud Toulany
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Wiley 2025-10-01
Sarja:	Molecular Oncology
Aiheet:	colorectal cancer KRAS mutation prognosis YB‐1 phosphorylation
Linkit:	https://doi.org/10.1002/1878-0261.70060
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!